Fragment-based drug design is increasingly used to identify suitable scaffolds in drug discovery. Whilst providing many advantages, working with low molecular weight fragments also impose challenges. Apart from inherently weak affinities in combination with low molecular weight, one has to handle solubility issues and secondary interactions that may appear at high concentrations. High sensitivity instrumentation is required to observe and verify binding, and the use of difficult targets increases the need for sensitivity even further. Software tools that take the challenges of working with fragments into account shortens the time to results, and increase the confidence in affinity estimations for LMW fragments. Surface Plasmon Resonance (S...
In the last decade, X-ray crystallography has matured to a powerful primary screening technique for ...
*S Supporting Information ABSTRACT: Most libraries for fragment-based drug discov-ery are restricted...
It is widely known that early estimates about the binding properties of drug candidates are importan...
International audienceINTRODUCTION:Fragment-based approaches have played an increasing role alongsid...
Fragment-based drug discovery is a validated approach for the discovery of drug candidates However, ...
Surface plasmon resonance (SPR) offers a method of biophysical fragment screening that is fast, effi...
Surface plasmon resonance (SPR) is one of the primary biophysical methods for the screening of low m...
AbstractSurface plasmon resonance (SPR) is one of the primary biophysical methods for the screening ...
Fragment-based drug discovery (FBDD) has become a widely accepted tool that is complementary to high...
<div><p>Surface Plasmon Resonance (SPR) is rarely used as a primary High-throughput Screening (HTS) ...
Fragment based drug discovery (FBDD) has been applied to two protease drug targets, MMP-12 and HIV-1...
SPR (Surface Plasmon Resonance) biosensor instruments are more and more equipped to sensitively meas...
In the last decade, X-ray crystallography has matured to a powerful primary screening technique for ...
*S Supporting Information ABSTRACT: Most libraries for fragment-based drug discov-ery are restricted...
It is widely known that early estimates about the binding properties of drug candidates are importan...
International audienceINTRODUCTION:Fragment-based approaches have played an increasing role alongsid...
Fragment-based drug discovery is a validated approach for the discovery of drug candidates However, ...
Surface plasmon resonance (SPR) offers a method of biophysical fragment screening that is fast, effi...
Surface plasmon resonance (SPR) is one of the primary biophysical methods for the screening of low m...
AbstractSurface plasmon resonance (SPR) is one of the primary biophysical methods for the screening ...
Fragment-based drug discovery (FBDD) has become a widely accepted tool that is complementary to high...
<div><p>Surface Plasmon Resonance (SPR) is rarely used as a primary High-throughput Screening (HTS) ...
Fragment based drug discovery (FBDD) has been applied to two protease drug targets, MMP-12 and HIV-1...
SPR (Surface Plasmon Resonance) biosensor instruments are more and more equipped to sensitively meas...
In the last decade, X-ray crystallography has matured to a powerful primary screening technique for ...
*S Supporting Information ABSTRACT: Most libraries for fragment-based drug discov-ery are restricted...
It is widely known that early estimates about the binding properties of drug candidates are importan...